Faes Farma Reports Second Quarter 2025 Earnings

Advertisement

Faes Farma (BME:FAE) Second Quarter 2025 Results

Key Financial Results

  • Revenue: €154.4m (up 15% from 2Q 2024).
  • Net income: €24.0m (down 14% from 2Q 2024).
  • Profit margin: 16% (down from 21% in 2Q 2024). The decrease in margin was driven by higher expenses.
earnings-and-revenue-growth
BME:FAE Earnings and Revenue Growth July 26th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Faes Farma Earnings Insights

Looking ahead, revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Pharmaceuticals industry in Europe.

Performance of the market in Spain.

The company's shares are down 3.8% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 1 warning sign for Faes Farma you should be aware of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About BME:FAE

Faes Farma

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.

Undervalued with adequate balance sheet.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0768.0% undervalued
279 users have followed this narrative
1 users have commented on this narrative
40 users have liked this narrative
GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.6% undervalued
80 users have followed this narrative
1 users have commented on this narrative
19 users have liked this narrative
TO
Tokyo
ABI logo
Tokyo on Anheuser-Busch InBev ·

EU#8 - Anheuser-Busch InBev: Courage, Capital, and the Discipline to Build an Empire

Fair Value:€89.4521.3% undervalued
4 users have followed this narrative
3 users have commented on this narrative
2 users have liked this narrative
OS
oscargarcia
AMZN logo
oscargarcia on Amazon.com ·

The capitalist colossus that makes your parcels magically appear, powers half the internet, and knows your shopping habits.

Fair Value:US$2801.8% undervalued
59 users have followed this narrative
1 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

CH
BAJAJ-AUTO logo
Chimichanga696 on Bajaj Auto ·

Bajaj Auto has seen a correction in its stock price after a strong rally, making it an attractive opportunity for investors.

Fair Value:₹15k31.2% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
BGD logo
RockeTeller on Barton Gold Holdings ·

Aussie’s Barton Gold, No Debt Miner with 1 Mill That Changes Everything

Fair Value:AU$22.4495.8% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MR
MRT23
ASIC logo
MRT23 on Ategrity Specialty Insurance Company Holdings ·

ASIC is a technology-differentiated E&S insurer compounding book value with a structurally improving combined ratio

Fair Value:US$3034.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.232.0% undervalued
69 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$561.9326.8% undervalued
1396 users have followed this narrative
2 users have commented on this narrative
12 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74018.2% undervalued
31 users have followed this narrative
3 users have commented on this narrative
32 users have liked this narrative